Literature DB >> 25857820

Advances in Toll-like receptor biology: Modes of activation by diverse stimuli.

Clare E Bryant1, Nick J Gay2, Stephane Heymans3,4, Sandra Sacre5, Liliana Schaefer6, Kim S Midwood7.   

Abstract

As we learn more about the biology of the Toll-like receptors (TLRs), a wide range of molecules that can activate this fascinating family of pattern recognition receptors emerges. In addition to conserved pathogenic components, endogenous danger signals created upon tissue damage are also sensed by TLRs. Detection of these types of stimuli results in TLR mediated inflammation that is vital to fight pathogenic invasion and drive tissue repair. Aberrant activation of TLRs by pathogenic and endogenous ligands has also been linked with the pathogenesis of an increasing number of infectious and autoimmune diseases, respectively. Most recently, allergen activation of TLRs has also been described, creating a third broad class of TLR stimulus that has helped to shed light on the pathogenesis of allergic disease. To date, microbial activation of TLRs remains best characterized. Each member of the TLR family senses a specific subset of pathogenic ligands, pathogen associated molecular patterns (PAMPS), and a wealth of structural and biochemical data continues to reveal the molecular mechanisms of TLR activation by PAMPs, and to demonstrate how receptor specificity is achieved. In contrast, the mechanisms by which endogenous molecules and allergens activate TLRs remain much more mysterious. Here, we provide an overview of our current knowledge of how very diverse stimuli activate the same TLRs and the structural basis of these modes of immunity.

Entities:  

Keywords:  Allergens; Toll-like receptors; endogenous stimuli; extracellular matrix; glycoproteins; nucleic acids; pathogen recognition; small leucine rich proteoglycans; structure

Mesh:

Substances:

Year:  2015        PMID: 25857820     DOI: 10.3109/10409238.2015.1033511

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  36 in total

Review 1.  Danger signals in oral cavity-related diseases.

Authors:  Jason G Kay; Jill M Kramer; Michelle B Visser
Journal:  J Leukoc Biol       Date:  2019-02-18       Impact factor: 4.962

Review 2.  GABAAR α2-activated neuroimmune signal controls binge drinking and impulsivity through regulation of the CCL2/CX3CL1 balance.

Authors:  Laure Aurelian; Irina Balan
Journal:  Psychopharmacology (Berl)       Date:  2019-04-27       Impact factor: 4.530

Review 3.  Toll-Like Receptor-4 Signaling Drives Persistent Fibroblast Activation and Prevents Fibrosis Resolution in Scleroderma.

Authors:  Swati Bhattacharyya; Kim S Midwood; Hang Yin; John Varga
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-10-01       Impact factor: 4.730

4.  Duplicated TLR5 of zebrafish functions as a heterodimeric receptor.

Authors:  Carlos G P Voogdt; Jaap A Wagenaar; Jos P M van Putten
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-19       Impact factor: 11.205

5.  Distinct microenvironmental cues stimulate divergent TLR4-mediated signaling pathways in macrophages.

Authors:  Anna M Piccinini; Lorena Zuliani-Alvarez; Jenny M P Lim; Kim S Midwood
Journal:  Sci Signal       Date:  2016-08-30       Impact factor: 8.192

Review 6.  Inflammasomes: Threat-Assessment Organelles of the Innate Immune System.

Authors:  Charles L Evavold; Jonathan C Kagan
Journal:  Immunity       Date:  2019-08-28       Impact factor: 31.745

Review 7.  Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity.

Authors:  Anna M Marzeda; Kim S Midwood
Journal:  J Histochem Cytochem       Date:  2018-01-31       Impact factor: 2.479

8.  Toll-like receptor 9 in systemic sclerosis patients: relation to modified Rodnan skin score, disease severity, and functional status.

Authors:  Tamer A Gheita; Safaa Sayed; Gada S Azkalany; Nouran Abaza; Nevin Hammam; A H Eissa
Journal:  Clin Rheumatol       Date:  2017-10-26       Impact factor: 2.980

Review 9.  Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy.

Authors:  Swati Bhattacharyya; John Varga
Journal:  Immunol Lett       Date:  2017-09-28       Impact factor: 3.685

Review 10.  Targeting TLR4 Signaling to Blunt Viral-Mediated Acute Lung Injury.

Authors:  Kari Ann Shirey; Jorge C G Blanco; Stefanie N Vogel
Journal:  Front Immunol       Date:  2021-07-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.